382 related articles for article (PubMed ID: 36421461)
1. Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia.
Morén C; Treder N; Martínez-Pinteño A; Rodríguez N; Arbelo N; Madero S; Gómez M; Mas S; Gassó P; Parellada E
Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36421461
[TBL] [Abstract][Full Text] [Related]
2. Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia.
Parellada E; Gassó P
Transl Psychiatry; 2021 May; 11(1):271. PubMed ID: 33958577
[TBL] [Abstract][Full Text] [Related]
3. NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms.
Snyder MA; Gao WJ
Schizophr Res; 2020 Mar; 217():60-70. PubMed ID: 30979669
[TBL] [Abstract][Full Text] [Related]
4. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
[TBL] [Abstract][Full Text] [Related]
5. The relevance of transdiagnostic shared networks to the severity of symptoms and cognitive deficits in schizophrenia: a multimodal brain imaging fusion study.
Qi S; Bustillo J; Turner JA; Jiang R; Zhi D; Fu Z; Deramus TP; Vergara V; Ma X; Yang X; Stevens M; Zhuo C; Xu Y; Calhoun VD; Sui J
Transl Psychiatry; 2020 May; 10(1):149. PubMed ID: 32424299
[TBL] [Abstract][Full Text] [Related]
6. Molecular substrates of schizophrenia: homeostatic signaling to connectivity.
Landek-Salgado MA; Faust TE; Sawa A
Mol Psychiatry; 2016 Jan; 21(1):10-28. PubMed ID: 26390828
[TBL] [Abstract][Full Text] [Related]
7. Adaptive Associations between Social Cognition and Emotion Regulation are Absent in Schizophrenia and Bipolar Disorder.
Rowland JE; Hamilton MK; Vella N; Lino BJ; Mitchell PB; Green MJ
Front Psychol; 2012; 3():607. PubMed ID: 23423878
[TBL] [Abstract][Full Text] [Related]
8. Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses.
Bortolato B; Miskowiak KW; Köhler CA; Vieta E; Carvalho AF
Neuropsychiatr Dis Treat; 2015; 11():3111-25. PubMed ID: 26719696
[TBL] [Abstract][Full Text] [Related]
9. Synapse-specific contributions in the cortical pathology of schizophrenia.
Seshadri S; Zeledon M; Sawa A
Neurobiol Dis; 2013 May; 53():26-35. PubMed ID: 23336981
[TBL] [Abstract][Full Text] [Related]
10. Frontal-posterior functional imbalance and aberrant function developmental patterns in schizophrenia.
Sun D; Guo H; Womer FY; Yang J; Tang J; Liu J; Zhu Y; Duan J; Peng Z; Wang H; Tan Q; Zhu Q; Wei Y; Xu K; Zhang Y; Tang Y; Zhang X; Xu F; Wang J; Wang F
Transl Psychiatry; 2021 Sep; 11(1):495. PubMed ID: 34580274
[TBL] [Abstract][Full Text] [Related]
11. Cognitive deficits in early-onset schizophrenia spectrum patients and their non-psychotic siblings: a comparison with ADHD.
Groom MJ; Jackson GM; Calton TG; Andrews HK; Bates AT; Liddle PF; Hollis C
Schizophr Res; 2008 Feb; 99(1-3):85-95. PubMed ID: 18083349
[TBL] [Abstract][Full Text] [Related]
12. Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort.
Fond G; Boyer L; Schürhoff F; Berna F; Godin O; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Leboyer M;
Schizophr Res; 2018 Nov; 201():373-380. PubMed ID: 29843964
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Structural Differences in Delusions Across Diagnoses: A Systematic Review.
Rootes-Murdy K; Goldsmith DR; Turner JA
Front Integr Neurosci; 2021; 15():726321. PubMed ID: 35140591
[TBL] [Abstract][Full Text] [Related]
14. [Social cognition in schizophrenia and autism spectrum disorder: Points of convergence and functional differences].
Le Gall E; Iakimova G
Encephale; 2018 Dec; 44(6):523-537. PubMed ID: 30122298
[TBL] [Abstract][Full Text] [Related]
15. Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations.
McNally JM; McCarley RW; Brown RE
Curr Psychiatry Rep; 2013 Mar; 15(3):346. PubMed ID: 23400808
[TBL] [Abstract][Full Text] [Related]
16. Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia.
Stansfield KH; Ruby KN; Soares BD; McGlothan JL; Liu X; Guilarte TR
Transl Psychiatry; 2015 Mar; 5(3):e522. PubMed ID: 25756805
[TBL] [Abstract][Full Text] [Related]
17. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onset.
Maziade M; Gingras N; Rodrigue C; Bouchard S; Cardinal A; Gauthier B; Tremblay G; Côté S; Fournier C; Boutin P; Hamel M; Roy MA; Martinez M; Mérette C
Br J Psychiatry; 1996 Sep; 169(3):361-70. PubMed ID: 8879724
[TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.
Jaaro-Peled H; Hayashi-Takagi A; Seshadri S; Kamiya A; Brandon NJ; Sawa A
Trends Neurosci; 2009 Sep; 32(9):485-95. PubMed ID: 19712980
[TBL] [Abstract][Full Text] [Related]
19. Impact of social anxiety on social cognition and functioning in patients with recent-onset schizophrenia spectrum disorders.
Achim AM; Ouellet R; Lavoie MA; Vallières C; Jackson PL; Roy MA
Schizophr Res; 2013 Apr; 145(1-3):75-81. PubMed ID: 23415473
[TBL] [Abstract][Full Text] [Related]
20. Reduced Sleep Spindles in Schizophrenia: A Treatable Endophenotype That Links Risk Genes to Impaired Cognition?
Manoach DS; Pan JQ; Purcell SM; Stickgold R
Biol Psychiatry; 2016 Oct; 80(8):599-608. PubMed ID: 26602589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
